13-113640228-G-C
Variant summary
Our verdict is Benign. Variant got -10 ACMG points: 0P and 10B. BP4_StrongBP6_ModerateBS2
The NM_007111.5(TFDP1):āc.1194G>Cā(p.Glu398Asp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000143 in 1,613,588 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (ā ).
Frequency
Consequence
NM_007111.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -10 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TFDP1 | NM_007111.5 | c.1194G>C | p.Glu398Asp | missense_variant | 12/12 | ENST00000375370.10 | NP_009042.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TFDP1 | ENST00000375370.10 | c.1194G>C | p.Glu398Asp | missense_variant | 12/12 | 1 | NM_007111.5 | ENSP00000364519.4 | ||
TFDP1 | ENST00000494812.1 | n.280G>C | non_coding_transcript_exon_variant | 3/3 | 3 | |||||
TFDP1 | ENST00000544902.5 | n.*910G>C | non_coding_transcript_exon_variant | 11/11 | 2 | ENSP00000438450.2 | ||||
TFDP1 | ENST00000544902.5 | n.*910G>C | 3_prime_UTR_variant | 11/11 | 2 | ENSP00000438450.2 |
Frequencies
GnomAD3 genomes AF: 0.0000525 AC: 8AN: 152250Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000161 AC: 4AN: 249070Hom.: 0 AF XY: 0.0000222 AC XY: 3AN XY: 134846
GnomAD4 exome AF: 0.00000958 AC: 14AN: 1461220Hom.: 0 Cov.: 31 AF XY: 0.00000963 AC XY: 7AN XY: 726944
GnomAD4 genome AF: 0.0000591 AC: 9AN: 152368Hom.: 0 Cov.: 33 AF XY: 0.0000671 AC XY: 5AN XY: 74504
ClinVar
Submissions by phenotype
not specified Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Jul 15, 2021 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at